Acer Therapeutics Inc. (ACER) NASDAQ
$0.90 0.90 (-)
Market Cap: $22.02M
As of 07/18/24 04:00 PM EDT. Market closed.
Acer Therapeutics Inc. (ACER)
NASDAQ
$0.90
0.90 (-)
Market Cap: $22.02M
As of 07/18/24 04:00 PM EDT. Market closed.
Add to Portfolio
Acer Therapeutics Inc., a pharmaceutical company, focuses on the acquisition, development, and commercialization of therapies for serious rare and life-threatening diseases. Its pipeline includes four clinical-stage candidates comprising EDSIVO for the treatment of vascular Ehlers-Danlos Syndrome in patients with a confirmed type III collagen mutation; ACER-001, a formulation of sodium ... read more
COMPANY PROFILE
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Christopher Schelling
Full Time Employees
30
CEO Compensation (Base)
$500,015
CEO Compensation (Total)
$834,230
Sector
Healthcare
Industry
Biotechnology
CEO
Mr. Christopher Schelling
Full Time Employees
30
CEO Compensation (Base)
$500,015
CEO Compensation (Total)
$834,230
URL
Address
One Gateway Center, Suite 351, MA, Newton, 02458.
PRICE CHART FOR ACER THERAPEUTICS INC.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
$0.90 - $0.90
52 week range
$0.90 - $0.90
Volume
0
Avg. Volume (30 days)
0
Market Cap
$22.02M
Dividend Yield
-
P/E
(0.47)
Shares Outstanding
24,463,700
Open
-
Previous Close
-
Days Range
$0.90 - $0.90
52 week range
$0.90 - $0.90
Volume
0
Avg. Volume (30 days)
0
Market Cap
$22.02M
Dividend Yield
-
P/E
(0.47)
Shares Outstanding
24,463,700
FINANCIAL STATEMENTS FOR ACER THERAPEUTICS INC.
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR ACER THERAPEUTICS INC.
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Schelling Chris | President & CEO | Nov 29, 2022 | Buy | $1.22 | 819,672 | 1,000,000 | 2,712,529 | Dec 01, 2022, 04:02 PM |
| ASELAGE STEVE | Director | Nov 29, 2022 | Buy | $1.22 | 409,836 | 500,000 | 483,741 | Dec 01, 2022, 04:01 PM |
| ASELAGE STEVE | Director | Dec 10, 2021 | Buy | $2.04 | 7,984 | 16,287 | 73,905 | Dec 13, 2021, 04:02 PM |
| ASELAGE STEVE | Director | Dec 09, 2021 | Buy | $2.15 | 2,016 | 4,334 | 65,921 | Dec 13, 2021, 04:02 PM |
| ASELAGE STEVE | Director | Jul 24, 2020 | Buy | $3.50 | 45,000 | 157,500 | 63,905 | Jul 28, 2020, 09:02 AM |
| DUNN JOHN MICHAEL | Director | Jul 24, 2020 | Buy | $3.50 | 21,428 | 74,998 | 27,380 | Jul 28, 2020, 09:01 AM |
| Joseph Donald | Chief Legal Officer and Secy | Jul 24, 2020 | Buy | $3.50 | 14,285 | 49,998 | 14,285 | Jul 28, 2020, 09:01 AM |
| Schelling Chris | President & CEO | Jul 24, 2020 | Buy | $3.50 | 142,857 | 500,000 | 1,892,857 | Jul 28, 2020, 09:00 AM |
| Andrews William T. | Chief Medical Officer | Mar 02, 2020 | Option Exercise | $3.28 | 3,142 | 10,306 | 5,858 | Mar 04, 2020, 04:25 PM |
| ASELAGE STEVE | Director | Jul 03, 2019 | Buy | $3.72 | 5,000 | 18,581 | 18,905 | Jul 05, 2019, 04:08 PM |
| TVM Life Science Ventures VII L.P. | Director | Aug 01, 2018 | Buy | $18.00 | 275,000 | 4,950,000 | 1,697,709 | Aug 22, 2018, 04:22 PM |
| TVM Life Science Ventures VI GmbH & Co KG | Director | Dec 12, 2017 | Buy | $12.00 | 333,333 | 3,999,996 | 1,422,709 | Jan 12, 2018, 02:33 PM |
| ASELAGE STEVE | Director | Dec 14, 2017 | Buy | $12.00 | 2,000 | 24,000 | 13,905 | Dec 18, 2017, 04:01 PM |
| BARABE TIMOTHY C | Director | Nov 18, 2016 | Sale | $0.55 | 14,914 | 8,210 | 20,719 | Nov 22, 2016, 07:31 AM |
| BARABE TIMOTHY C | Director | Sep 17, 2014 | Buy | $1.15 | 10,000 | 11,500 | 16,000 | Sep 18, 2014, 08:00 AM |
| Warma Neil K | President & CEO | Sep 16, 2014 | Buy | $1.11 | 10,000 | 11,100 | 107,634 | Sep 17, 2014, 08:00 AM |
| Seaman Scott B | Director | Dec 18, 2013 | Buy | $1.70 | 30,000 | 51,000 | 40,913 | Dec 18, 2013, 03:58 PM |
| Radhakrishnan Karthik | Chief Financial Officer | Dec 18, 2013 | Buy | $1.70 | 8,000 | 13,600 | 58,000 | Dec 18, 2013, 03:55 PM |
| Warma Neil K | President & CEO | Sep 24, 2013 | Option Exercise | $1.91 | 8,076 | 15,425 | 17,315 | Sep 26, 2013, 09:15 PM |
| JORDEN DAVID EMERSON | Director | Sep 24, 2013 | Option Exercise | $1.91 | 61,912 | 118,252 | 293,456 | Sep 26, 2013, 09:00 PM |
| Seaman Scott B | Director | Sep 24, 2013 | Option Exercise | $1.91 | 269,182 | 514,138 | 518,708 | Sep 26, 2013, 08:57 PM |
| Radhakrishnan Karthik | Chief Financial Officer | Aug 08, 2013 | Buy | $1.50 | 50,000 | 75,000 | 50,000 | Aug 09, 2013, 08:00 AM |
| JORDEN DAVID EMERSON | Director | Jun 30, 2013 | Option Exercise | $1.54 | 4,450 | 6,853 | 231,544 | Jul 02, 2013, 02:57 PM |
| Warma Neil K | President & CEO | Jun 30, 2013 | Option Exercise | $1.54 | 581 | 895 | 9,239 | Jul 02, 2013, 02:49 PM |
| Seaman Scott B | Director | Jun 30, 2013 | Option Exercise | $1.54 | 19,345 | 29,791 | 249,526 | Jul 02, 2013, 02:42 PM |
| Warma Neil K | President & CEO | Dec 31, 2012 | Option Exercise | $1.33 | 600 | 798 | 8,658 | Jan 28, 2013, 05:43 PM |
| Seaman Scott B | Director | Dec 31, 2012 | Option Exercise | $1.33 | 19,978 | 26,571 | 230,181 | Jan 24, 2013, 06:50 PM |
| JORDEN DAVID EMERSON | Acting Chief Financial Officer | Dec 31, 2012 | Option Exercise | $1.33 | 4,595 | 6,111 | 227,094 | Jan 24, 2013, 06:15 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Schelling Chris | President & CEO | 11/29/2022 | 1,000,000 |
| ASELAGE STEVE | Director | 11/29/2022 | 500,000 |
| ASELAGE STEVE | Director | 12/10/2021 | 16,287 |
| ASELAGE STEVE | Director | 12/09/2021 | 4,334 |
| ASELAGE STEVE | Director | 07/24/2020 | 157,500 |
| DUNN JOHN MICHAEL | Director | 07/24/2020 | 74,998 |
| Joseph Donald | Chief Legal Officer and Secy | 07/24/2020 | 49,998 |
| Schelling Chris | President & CEO | 07/24/2020 | 500,000 |
| Andrews William T. | Chief Medical Officer | 03/02/2020 | 10,306 |
| ASELAGE STEVE | Director | 07/03/2019 | 18,581 |
| TVM Life Science Ventures VII L.P. | Director | 08/01/2018 | 4,950,000 |
| TVM Life Science Ventures VI GmbH & Co KG | Director | 12/12/2017 | 3,999,996 |
| ASELAGE STEVE | Director | 12/14/2017 | 24,000 |
| BARABE TIMOTHY C | Director | 11/18/2016 | 8,210 |
| BARABE TIMOTHY C | Director | 09/17/2014 | 11,500 |
| Warma Neil K | President & CEO | 09/16/2014 | 11,100 |
| Seaman Scott B | Director | 12/18/2013 | 51,000 |
| Radhakrishnan Karthik | Chief Financial Officer | 12/18/2013 | 13,600 |
| Warma Neil K | President & CEO | 09/24/2013 | 15,425 |
| JORDEN DAVID EMERSON | Director | 09/24/2013 | 118,252 |
| Seaman Scott B | Director | 09/24/2013 | 514,138 |
| Radhakrishnan Karthik | Chief Financial Officer | 08/08/2013 | 75,000 |
| JORDEN DAVID EMERSON | Director | 06/30/2013 | 6,853 |
| Warma Neil K | President & CEO | 06/30/2013 | 895 |
| Seaman Scott B | Director | 06/30/2013 | 29,791 |
| Warma Neil K | President & CEO | 12/31/2012 | 798 |
| Seaman Scott B | Director | 12/31/2012 | 26,571 |
| JORDEN DAVID EMERSON | Acting Chief Financial Officer | 12/31/2012 | 6,111 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING FOR ACER THERAPEUTICS INC.
STOCK BUYBACKS FOR ACER THERAPEUTICS INC.
Period of Report: 06/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2023
15.87%
1Q
06/30/2022
38.35%
4Q
BUYBACK ANNOUNCEMENT(S) FOR ACER THERAPEUTICS INC.
LOADING...